The anti-HCC mechanism of action of peretinoin has previously been suggested to be a result of induction of cell apoptosis [20,21], enhancement of cell differentiation [21,22], suppression of cell proliferation by elevation of P21 protein expression and suppression of cyclin D1 expression [23,24]. Here, CCND1 is linked to hepatocellular carcinoma.